Home » Blog » Sunshine Act Database Delayed & Medicare Considering Clinical Pathways?

Sunshine Act Database Delayed & Medicare Considering Clinical Pathways?


IP Blog | Dave Melin | August 17, 2014

BioBlogWeeklyThis week in healthcare, the Sunshine Act payments database has been taken offline and its rollout delayed, and Medicare may be ready for some oncology clinical pathways in 2014.

Sunshine Act payments database offline, rollout of initiative delayed

After complaints that some doctors could see other doctors’ payments, CMS took down its payments database to try to correct the issue. In a statement, CMS said, “We do not want physicians to see data which does not belong to them, so we are temporarily suspending Open Payments registration. We will also work with the responsible companies to make them aware of the issue and correct the root data.”

Is Medicare Ready for Oncology Clinical Pathways?

“CMS is reviewing a proposal by McKesson and NCCN to utilize their oncology clinical pathways. If the proposal is accepted, McKesson believes that CMS will roll it out as a pilot project in certain oncology practices and hospital settings sometime in 2014.”

Aetna, Cigna report falling enrollment in ACA plans

In a recent article both Aetna and Cigna reported that the number of ACA plan enrollees was dropping. “Aetna reported that fewer than 600,000 of the 720,000 people who had signed up for Obamacare policies as of May 20 were paying premiums at the end of June–and the company expects that number to fall to about 500,000 by the end of the year.”

The Association of Community Cancer Centers Launches Oncology Drug Database

Last week the Association of Community Cancer Centers (ACCC) announced its new oncology drug database. The database will provide “immediate access to information on oncology drug coding, billing, and reimbursement” and is geared toward “physicians, nurses, pharmacists, administrators, practice managers, coders and billers, and financial advocates.”

Want more health care landscape updates and insights? Follow us on Twitter @innovpartners.


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *